Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial (vol 39, pg 1972, 2016)

被引:3
作者
Aroda, Vanita R.
Rosenstock, Julio
Wysham, Carol
Unger, Jeffrey
Bellido, Diego
Gonzalez-Galvez, Guillermo
Takami, Akane
Guo, Hailing
Niemoeller, Elisabeth
Souhami, Elisabeth
Bergenstal, Richard M.
机构
关键词
D O I
10.2337/dc17-er06d
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:809 / 809
页数:1
相关论文
共 1 条
[1]   Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial [J].
Aroda, Vanita R. ;
Rosenstock, Julio ;
Wysham, Carol ;
Unger, Jeffrey ;
Bellido, Diego ;
Gonzalez-Galvez, Guillermo ;
Takami, Akane ;
Guo, Hailing ;
Niemoeller, Elisabeth ;
Souhami, Elisabeth ;
Bergenstal, Richard M. .
DIABETES CARE, 2016, 39 (11) :1972-1980